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Summary 
Pathophysiology of Duchenne Muscular Dystrophy is still elusive. Although progressive 
damage to muscle fibres is a cause of muscle deterioration leading to premature death, there is 
a growing body of evidence indicating that the triggering effects of DMD mutation are 
present at the very early stage of muscle development. Previously, elevated activity of P2X7 
receptors and increased store-operated calcium entry were shown in myoblasts derived from 
mdx mice. Here, the metabotropic extracellular ATP/UTP-evoked response has been 
investigated. Sensitivity to antagonist, effect of gene silencing and cellular localization studies 
showed that elevated purinergic responses in mdx myoblasts have been caused by increased 
expression of P2Y2 but not P2Y4 receptors. These alterations have physiological implications 
as shown by reduced motility of mdx myoblasts upon treatment with P2Y2 agonist. The 
ultimate increase in intracellular calcium in dystrophic cells reflected complex alterations of 
calcium homeostasis identified in the RNA seq data and with significant modulation at the 
protein level including a decrease of Gq11 subunit , PMCA, IP3-receptor and elevation of 
PLC, SERCA and NCX. In conclusion, whereas specificity of dystrophic myoblast 
excitation by extracellular ATP is determined by specific receptor overexpression, the 
intensity of this altered response depends on relative activities of downstream calcium 
regulators that also accompany the Dmd gene mutation. These results confirm that phenotypic 
effects of DMD emerge in undifferentiated muscle cells and not only due to the absence of 
dystrophin protein in myofibres. Therefore, the pathogenesis of DMD and the relevance of 
current therapeutic approaches may need re-evaluation. 
1. Introduction
Duchenne muscular dystrophy (DMD) is a lethal inherited disorder causing severe 
progressive muscle loss with sterile inflammation accompanied by cognitive and behavioural 
impairments and decreased bone strength. The disease is caused by the lack of dystrophin due 
to out-of-frame mutations in the DMD gene and the diversity of symptoms illustrates the 
importance of dystrophin in a range of cells. Indeed, DMD is the largest human gene known 
with 79 exons encoding 3 full-length (427 kDa) expressed in temporally-controlled and 
tissue-specific manners in muscle but also in non-muscle cells. The five progressively-
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shortened isoforms (Dp412, Dp260, Dp140, Dp116 and Dp71) also present specific spatio-
temporal patterns of expression, occurring as early as in embryonic stem cells and they have 
distinct roles, which are only partially understood [1]. Therefore, DMD is a multi-functional 
gene with a complex spatio-temporal expression pattern. Yet, since the life-threatening effects 
of DMD mutations present in striated muscles, investigations have focused on the full-size 
dystrophins, which have been attributed with the key role in protecting myofibres.  
Dystrophin there localizes to the cytoplasmic face of the sarcolemma where it anchors a set of 
dystrophin-associated proteins (DAP) tethering this complex to the intracellular cytoskeleton 
and extracellular matrix proteins [2]. The current understanding is that the dystrophin-DAP 
provides structural stability to the myofibre sarcolemma and its loss triggers muscle 
degeneration by destabilization of this membrane, allows extracellular Ca
2+
 influx leading to
abnormal intracellular calcium signalling and a downstream cascade eventually resulting in 
muscle cell death. The evidence for this mechanical/structural instability triggering this 
complex train of pathological events is that the re-expression of dystrophin improves structure 
and function of dystrophic muscles. However, this does not necessarily prove that the disease 
starts with the absence of dystrophin in myofibres. Indeed, RNAi mediated knock-down of the 
full-length dystrophin expression in adult mouse did not trigger muscle degeneration despite a 
loss of protein from the sarcolemma [3]. Furthermore, the knockout of the DAP protein 
dystroglycan in mature muscle was associated with loss of dystrophin from the sarcolemma 
but caused no necrosis or sarcolemmal fragility [4]. These results indicate a need for critical 
re-evaluation of current views regarding the pathogenesis of DMD and the therapeutic 
strategies being developed [5]. It is important to consider whether the absence of dystrophin 
in fully differentiated muscle fibres is the mechanism of disease and therefore, whether 
dystrophin re-expression in myofibres would cure this disease. Indeed, dystrophin is 
expressed early in embryogenesis (mouse E9.5) and its absence in mdx mouse severely 
disrupts muscle development due to stem cell loss and disrupted muscle patterning [6]. The 
absence of DMD gene expression also affects stem cells leading to the intrinsic exhaustion of 
stem cells pool thus compromising muscle regeneration [7, 8]. This abnormality has been 
linked to the absence of the full-length dystrophin in activated satellite cells, where it 
regulates cell polarity and reduced number of myogenic progenitors [9]. A recent study linked 
the DAP in muscle stem cells undergoing asymmetric division with the epigenetic activation 
[10]. Furthermore, myogenic cells from both Duchenne patients [11, 12] and mdx mice [13] 
show abnormalities of a range of important functions including altered proliferation and 
differentiation and defects of energy metabolism with disorganized mitochondrial networks 
[14]. Moreover, a purinergic phenotype involving an increased expression and activity of 
P2XR7 receptors has been identified in myoblasts of the mdx mouse model of Duchenne type 
muscular dystrophy [15, 16] as well as in human DMD lymphoblasts [17]. Further analyses 
led to a discovery of a novel mechanism of P2XR7-evoked autophagic death in dystrophic 
muscle [18]. Finally, ablation or pharmacological inhibition of P2RX7 significantly reduced 
the disease progression in the mdx model of DMD [19, 20, 21]. 
Besides the aberrant ionotropic response to extracellular ATP, we have also found 
increased activity of store-operated calcium entry mechanisms in dystrophic myoblasts [22]. 
These and other studies demonstrate that abnormalities of calcium homeostasis in DMD occur 
in myoblasts and not only in fully differentiated myofibres and that they involve alterations of 
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specific cellular mechanisms rather than mechanical membrane instability. 
Indeed, here we present evidence of a profound alteration of calcium homeostasis in 
myoblasts with the mutant Dmd gene, which involves the metabotropic response to eATP 
combined with dysregulation of the intracellular calcium machinery. Substantially increased 
activity of P2RY2 was identified in ATP- or UTP- stimulated dystrophic mouse myoblasts. 
While this effect could be attributed to the increased P2RY2 levels in the plasma membrane, 
the specificity of calcium responses in mdx myoblasts extends beyond the stimulation of 
P2RY2. The height and shape of elevated calcium transients reflect the combination of both 
the increased receptor activity and other significantly altered proteins involved in calcium 
signalling regulation in these cells.  
2. Material and Methods
2.1 Cell culture  
Immortalized mdx mouse and dystrophin-positive control (w/t) myoblasts were used. 
These two cell lines were of the same genetic background, as the two mouse strains from 
which the cells were derived originated from the same parental inbred mouse strain H2Kb-
tsA58 (“immorto mouse”), expressing the SV40 large T antigen gene with the tsA58 
mutation. The H2Kb-tsA58 mdx strain was established by crossing male mouse homozygous 
for H2Kb-tsA58 with female mdx mice [23]. Mdx and w/t cells used here are highly 
homogenous populations differing only in the presence or absence of a point mutation in the 
dystrophin gene exhibiting muscle phenotype and myogenic potential following 
differentiation [16, 24, 25, 26]. Cells were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM, Sigma Chemical Company, St. Louis, MO, USA) supplemented with 20% fetal calf 
serum, 4 mM L-glutamine, 100 unit/ml penicillin, 100 μg/ml streptomycin, and 20 unit/ml 
murine γ-interferon (Invitrogen, San Diego, CA, USA) at 33°C. Under such conditions a 
differentiation of these cells was efficiently prevented. Moreover both cell lines were also 
cultured at 37°C in absence of -interferon in KnockOut DMEM (Invitrogen) supplemented 
with 10% v/v KSR (Knockout Serum Replacement, Invitrogen), 5% v/v DHS (Donor Horse 
Serum, Sera Labs) and 2 mM L-glutamine. Under these conditions the cells exhibits 
phenotypic properties of primary myoblasts. Such an approach allows to maintain primary-
like (“de-immortalised”) cells because of prevented expression of the rtsA58-mutated T-large 
antigen-encoding gene. 
2.2 RNAseq 
Immortalised myoblast cell lines were cultured in immorto conditions to produce 4 
populations of each genotype growing apart for 2 passages and then replated and cultured for 
48 hours in primary myoblast conditions at 37°C with 5 % CO2 in IFN-γ free medium (see 
above). 
Total RNA was extracted using an RNEasy plus universal mini kit (QIAGEN 73404) 
following manufacturer’s instructions. Briefly, cells were washed 3 times with warm DPBS 
before being lysed directly on the culture plate by adding QIAZOL lysing buffer and using a 
cell scraper to disrupt the cells. Samples were then treated as per provided protocol. 
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After extraction, total RNA samples were sent to THERAGEN ETEX (Republic of Korea) for 
quality control and sequencing. Quality was assessed using an Agilent Bioanalyzer 2100, with 
a minimum RNA integrity number (RIN) of 7.0 or greater being required. Libraries were 
prepared using an Illumina TruSeq stranded total RNA kit, including ribodepletion using the 
Ribo-Zero Human/Mouse/Rat kit to remove ribosomal RNA. Libraries were sequenced in a 
paired-end 100bp run using an Illumina HiSeq 2500 sequencing platform. 
Quality control of raw fast reads was conducted using fastQC [27]. Reads were trimmed using 
trim-galore [28] with parameters-to remove adapter sequence and low quality sequence tails. 
Trimmed reads were mapped against the GRCm38 Mus musculus genome from Ensembl 
using the STAR universal RNA seq aligner [29] with parameters ‘“--outSAMmultNmax 300 -
-outSAMstrandField intronMotif’. 
Differential expression analysis was conducted using the DESeq2 package [30] in R 
[31]. Gene models were taken from Ensembl version 91, and read counts over unique genes 
were quantified using the summarize Overlaps function in the GenomicAlignments package 
[32] using mode “Union”. P values were adjusted for multiple testing by using the Benjamini
and Hochberg correction [33]. Significantly differentially expressed genes were identified
based on a fold-change of 2-fold or greater (up- or downregulated) and an adjusted p-value
less than 0.05. Gene ontology analysis was conducted using the clusterProfiler package [34].
2.3 RNA extraction, reverse transcription and quantitative RT-PCR 
Total RNA was isolated using Trizol method (TRI reagent, T9424; Sigma). The 
quality and quantity of samples were determined using a NanoDrop spectrophotometer. Only 
RNA with an absorbance ratio 260/280 between 1.8 - 2.0 was used to reverse transcription. 
Complementary DNA (cDNA) was synthesized from 2 µg of total RNA using First Strand 
cDNA Synthesis Kit with M-MLV reverse transcriptase and oligo(dT) primers (#K1612, 
Thermo Fischer Scientific), according to the manufacturer’s instructions.  
RT-qPCR was performed using TaqMan Fast Universal PCR Master Mix (4352042, 
Applied Biosystems)  and TaqMan Gene Expression Assays (the primers ID: Mm 
01274119_m1 for P2RY2, Mm 00445136_s1 for P2RY4) on the 7500 ABI Prism Real-Time 
PCR System (Applied Biosystems). The level of expression of target genes were normalized 
to the expression of GAPDH (primer ID: Mm99999915_g1) housekeeping gene. Analysis of 
relative gene expression data were determined by 2-ΔΔCt method using StepOne Software. 
2.4 Cell lysis, protein extraction and analysis 
Proteins were extracted from adherent cells by scraping into extraction buffer (1x 
LysisM, 1x protease inhibitor cocktail, 2 x phosphatase inhibitor cocktail (all Roche), 2 mM 
sodium orthovanadate (Sigma) suspending with the use of automatic pipets followed by 
repeatedly  forcing through the syringe needle (0.5  mm in diameter) and incubation of the 
suspension on ice for 20 min. After centrifugation (15 000 x g, for 20 min at 4
o
C) protein
concentrations in supernatants collected were determined using a Bradford protein assay (Bio-
Rad). Remaining supernatants were mixed with sample buffer at 3:1 
v
/v ratio, heated for 5 min
at 95

C and chilled on ice and stored at -20
o
C. Proteins (20 µg of each sample) were separated
on 0.1% SDS-polyacrylamide gels (6-12% 
w
/v depending on the molecular mass of protein)
and electroblotted onto Immobilon-PVDF Transfer Membrane (Merck Millipore). Blots were 
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blocked in 5% 
w
/v non-fat milk or 5% BSA (Albumin, Bovine Serum, 12659, Merck 
Millipore) powder solved in 1 x TBST, 0.01% 
v
/v Tween-20 (Sigma) for 1h at room 
temperature (RT) prior to probing with appropriate primary antibody diluted in a blocking 
buffer containing 2.5% milk or 5% BSA (incubated overnight at 4ºC with agitation). To 
identify proteins of interest following primary antibodies were applied: P2RY2 (1:270, APR-
10) and P2RY4 (1:300, APR-006; all Alomone Labs), calsequestrin (ab126241), calreticulin
(ab128885), SERCA1 (ab124501) and SERCA2 (ab91032; all diluted 1:1000, Abcam),
Gαq11 (1:1000, 06-709 Merck Millipore), PLCβ isoforms 1-4 (sc-5291, sc-515912, sc-
133231, sc-166131, respectively; all diluted 1:100, Santa Cruz Biotechnology), NCX1
(1:1000, R3F1 Swant) and NCX3 (1:500, ab84708 Abcam) and IP3R (diluted 1:1000 in BSA
solution as described above, #8568 Cell Signaling Technology). Then membranes were
washed (3x) with 1x PBST for 10 min each wash and incubated with anti-Rabbit (diluted
1:5000, ab6721, Abcam) or anti-Mouse (1:3000, ab6728, Abcam) horseradish peroxidase-
conjugated secondary antibody for 1h at RT.
Specific protein bands were visualized using luminol-based substrates (Millipore) and 
images obtained using a Fusion FX (Vilber Lourmat). β-tubulin (1:10000, ab21058), Na+-K+ 
ATPase (1:200, ab7671) and caveolin (1:2000, ab2910; all Abcam) antibodies were used as a 
protein-loading control dependent on the protocol. Densitometric analyses of specific protein 
bands were made using exposure times within the linear range and the integrated density 
measurement function of BIO-1D (Vilber Lourmat). All experiments were repeated at least 3 
times with similar results obtained in each replicate. 
2.5 siRNA transfection 
P2RY2 gene silencing was performed with the use of short interfering RNA (Silencer 
Select Pre-designed siRNA ID #s71197, Invitrogen, Thermo Fisher Scientific. Scrambled 
siRNA oligonucleotide (Silence Select Negative Control Scramble siRANA #4390847, 
Invitrogen) was used as a negative control. The sequence of P2RY2 siRNA were as follows: 
sense sequence 5’- CCGUAAUCCUGGUCUGUUAtt -3’antisense sequence 3’- 
UAACAGACCAGGAUUACGGaa -5’. 
Mdx and wt myoblasts were transfected with 50 nM siRNA using 3 µl/ml Lipofectamine 
RNAiMAX (#13778, Invitrogen). The transfection was carried out for 72 h in the medium as 
described above but without antibiotics and then cells were collected and analysed by Western 
blotting.  
2.6 Isolation of the plasma membrane fraction 
For isolation of membrane, around 25 x 106 cells were trypsinised, washed in ice-cold 
PBS, collected by centrifugation at 200 x g for 3 min and the cell pellet washed again with 
ice-cold PBS and finally the pellet was resuspend in cold Buffer A included in commercial 
Plasma Membrane Protein Extraction Kit (101Bio, #P503, Thermo Fisher Scientific). The 
isolation of the plasma membrane proteins was carried out according to the manufacturer’s 
instruction. The extract plasma membrane proteins were analysed by Western blotting as 
described above. 
7 
2.7 [Ca
2+
]c measurements in myoblasts in vitro
Myoblasts were cultured on glass coverslips in a 6-well plate (500 000 cells/well) for 
48 h under conditions described above. Cells (70–80% confluent) were loaded with 1 M 
Fura 2 AM (Molecular Probes, Oregon) in culture medium for 15 min at 33°C in a humidified 
atmosphere of 95% O2 and 5% CO2. The cells were then washed twice with the solution 
composed of 5 mM KCl, 1 mM MgCl2, 0.5 mM Na2HPO4, 25 mM HEPES, 130 mM NaCl, 1 
mM pyruvate, 5 mM D-glucose, and 0.1 mM CaCl2, pH 7.4 and the coverslips were mounted 
in a cuvette containing 3 ml of either the nominally Ca
2+
-free assay solution (as above but 0.1
mM CaCl2 was replaced by 0.05 mM EGTA) or Ca
2+
-containing assay solution (as above but
with 2 mM CaCl2) and maintained at RT in a spectrofluorimeter (Shimadzu, RF5001PC).  
Fluorescence was recorded at 510 nm with excitation at 340 and 380 nm. At the end of each 
experiment the Fura 2 fluorescence was calibrated by addition of 8 M ionomycin to 
determine maximal fluorescence followed by addition of EGTA to complete removal of Ca
2+
.
Cytosolic Ca
2+
 concentration [Ca
2+
]c was calculated according to Grynkiewicz et al. [35]. The
cells were treated with 500 µM and 1 mM ATP, 100 µM and 500 µM UTP (both Sigma) and 
10 µM AR-C 118925XX (216657-60-2, TOCRIS Bioscience) applied 10 min prior to the 
addition of ATP and UTP. Each experiment was repeated at least 5 times.  
2.8 Immunocytofluorescence (ICC) 
Cells were cultured on coverslips (50-60 %) in growth medium. After rinsed twice 
with cold PBS (w/o calcium and magnesium) the myoblasts were fixed in a 4% 
w
/v
paraformaldehyde solution (PFA) in PBS for 15 min on ice. Then cells were permeabilized 
using PBS with 0.1% Triton X-100 for 5 min and blocked in a 5% 
v
/v goat serum (GS, Normal
Goat Serum, S-1000, Vector Laboratories IVD) in PBS for 1 h at RT and incubated overnight 
at 4°C with primary antibodies (anti-P2RY2 and anti-P2RY4, as described above, diluted 
1:100 in blocking buffer). The secondary antibody (diluted 1:1000 in 5% GS in PBS, Alexa 
Fluor
®
488 goat anti-Rabbit, Thermo Fisher Scientific) was added for 1 h RT in dark. Then
myoblasts were rinsed 3 times for 10 min each wash with agitation between each steps of ICC 
protocol. After staining, cells on coverslips were mounted onto microscope slides sealed in 
Glycergel Mounting Medium with DAPI (H-1200 VectaShield
®
, Vector Laboratories) prior to
imaging. Images were obtained using a confocal microscope (Zeiss Spinning Disk Confocal 
Microscope) and image analysis was performed by using ImageJ software. 
2.9 Random motility assay 
To perform random migration assays 15,000 myoblasts (mdx and w/t) were seeded 
into 24-well cell culture plate and grown for 30 h in an appropriate culture medium. Then, 
multiple different well areas per each cell type were photographed in the bright field or DIC 
Nomarski contrast using HC PL APO 10x/0.40 Dry objective (Leica Microsystems GmbH) 
every 15 min for 6 h on inverted DMI6000 microscope (Leica Microsystems GmbH) 
equipped with DFC350FXR2 CCD camera (Leica Microsystems GmbH) and an 
environmental chamber (PeCon GmbH). Acquired time-lapse movies were exported to TIFF 
format and aligned to compensate possible drift using an ImageJ plugin. Subsequently, at least 
15 cells of each experimental condition were tracked semi-automatically in the time-lapse 
movies using Track Objects plug-in in Leica MM AF powered by MetaMorph® software 
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(Leica Microsystems GmbH). Cells dividing or colliding with other cells were excluded from 
the analysis. Obtained cell coordinates were subsequently imported into Matlab R2016b 
software (MathWorks, Inc.) and the movement parameters were calculated using a Matlab 
script. Each experiment was performed at least in triplicate. Statistical analysis was performed 
using Student’s t test. 
2.10 Data analysis 
Data are expressed as a mean value ± standard deviation (SD). Statistical significance 
was assessed by Student’s t-test A p value of <0.05 was considered statistically significant 
where n=3-5 for PCR and Western data, and n=3-9 for other analyses (“n” represents the 
number of independent experiments with cells derived from different passages).  
3. Results
3.1  ATP sensitive nucleotide receptors 
RNASeq analysis was performed as described to identify key transcription alterations 
between dystrophic (referred to as mdx) and wild type (w/t) myogenic immorto cells cultured 
under the primary myoblast conditions (Young et al., 2015, 2018). Differential expression 
analysis revealed a striking global transcriptional change as a result of the mdx mutation, with 
996 genes upregulated and 1,134 genes downregulated in dystrophic myoblasts (Fig. 1A and 
B). While global differential expression analyses will be presented elsewhere (manuscript in 
preparation), here we focussed on the purinergic phenotype, which is clearly caused by the 
Dmd gene mutation. In particular, we confirmed significant upregulation (4.8-fold increase, p 
= 7.39e-40) of the P2RX7 transcript, which has been previously categorised (Yeung et al., 
2006, Young et al., 2012, etc.). In addition, we saw significant differential expression, albeit 
at lower magnitude, for P2RX4 (1.8-fold increase, p = 1.16e-16) and P2RX6 (1.5-fold 
downregulated, p = 7.02e-6). Conversely, no significant differences were seen for P2RX5 
(Fig. 2).      
Stimulation with ATP or UTP in the presence of 2 mM CaCl2 in the extracellular 
milieu resulted in a transient increase in the cytosolic [Ca
2+
], that was substantially stronger in
mdx than w/t cells (Suppl. Fig 1). Under such experimental conditions, [Ca
2+
]c peak is a
resultant of at least three mechanisms directly responsible for the elevation of cytosolic Ca
2+
concentration. These include: (i) Ca
2+
 influx through P2RX channels and (ii) store-operated
calcium entry (SOCE), which both allow extracellular Ca
2+
 to flow into the cell. Both
mechanisms have been identified and analysed by us previously in immortalized and primary 
w/t and mdx myoblasts [15, 22]. The third mechanism concerning the eATP-evoked response 
is Ca
2+
 release from the ER stores due to stimulation of metabotropic nucleotide receptors of
the P2RY family. This step is also a prerequisite for SOCE. Moreover, the height and 
temporal pattern of the [Ca
2+
]c peaks, irrespectively of their origin, are modified by other
processes shaping calcium transients in excited cells. 
To avoid a concomitant stimulation of P2RXs (by ATP) or an activation of the store-
operated Ca
2+
 entry following depletion of the ER stores, calcium responses of myoblasts to
ATP or UTP were tested under Ca
2+
-free conditions. Thus, an intensity of calcium release
from the ER was first of all considered as a resultant of activities of P2RYs and other proteins 
involved in the PM–ER signal transduction.  
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Fig. 3 displays a calcium response of w/t and mdx myoblasts to ATP (Fig. 3A and B) 
or UTP (Fig. 3C and D). These agonists stimulate both P2RY2 and P2RY4 but ATP 
additionally exhibits small affinity to other P2RYs while UTP is particularly specific to 
P2RY2.  Wild type myoblasts were only slightly susceptible to stimulation by ATP or UTP 
while mdx strongly responded to both nucleotides.  
Significant differential expression was detected in the RNA seq data for P2RY 
receptors P2RY1 (13.6-fold upregulated, p = 5.69e-3), P2RY2 (5.9-fold upregulated, p = 
4.84e-4), and P2RY6 (4.8-fold downregulated, p = 2.09e-2), although detection of these genes 
was very low (FPKM < 0.2). P2RY4 was almost undetectable and showed no change in mdx 
samples. Given the increased metabotropic response to eATP in dystrophic cells, and our 
previous studies, which indicated a P2RY component in the purinergic response in mdx cells 
[15], we performed qPCR and Western blotting analysis of P2RY2 and P2RY4 (the two P2Y 
receptors responding to eATP) to validate the results from the RNA seq with more sensitive 
assays. As with the RNAseq data, much higher levels of P2RY2 transcript were found by 
qPCR in mdx compared to w/t myoblasts (Fig. 4), whilst P2RY4 was undetectable by qPCR. 
Surprisingly however, a band corresponding with the predicted molecular mass of P2RY4 
receptor was detected by Western blotting and this band was substantially stronger in mdx 
than in w/t myoblasts (Fig. 4). However, further analysis of plasma membrane proteins 
revealed that the P2RY2 was predominantly found in the membrane fraction and with 
significantly increased levels in dystrophic myoblasts (Fig. 5 and 6). In contrast, P2RY4 band 
was present in the cytosol but almost undetectable in the membrane fraction of mdx and w/t 
cells. This cellular localisation made the putative receptor contribution to the extracellular 
ATP responses rather unlikely. Immuno-localisation of P2RY2 receptor in myoblasts 
membrane (Fig. 6) confirmed this conclusion but also revealed a strong signal in the nuclei in 
addition to cytoplasmic staining. 
Indeed, substantially reduced calcium response to ATP or UTP in the presence of a 
specific P2RY2 antagonists (AR-C118925XX) (see. Fig. 3) confirmed a leading role of 
P2RY2 in this process. UTP-evoked calcium response is selective and therefore more 
efficiently blocked by AR-C118925XX. Finally, inhibition of UTP-induced Ca
2+
 release in
cells with siRNA silenced P2RY2 expression confirmed calcium response to be P2Y2-evoked 
(Fig. 7). This approach also allowed us to confirm the specificity of the band detected with 
anti-P2RY2 antibodies. This was important as the in-gel mobility of this protein reported by 
various authors differs significantly  [36. 37, 38 39]. As shown in Fig. 7, the band of a 
reduced intensity upon treatment of cells with P2RY2-specific siRNA corresponds to protein 
of a molecular mass slightly below 70 kDa, which is in agreement with data previously 
published by Choi et al., 2013 [36]. In summary, the qPCR transcript expression data in 
agreement with increased P2RY2 protein, silencing and pharmacological inhibitor study were 
all in line with the P2RY2 being responsible for the elevated nucleotide-evoked Ca
2+
 release
in dystrophic myoblasts (Fig. 3). Importantly, we further found that the elevated P2RY2 and 
an increased intensity of calcium response upon stimulation of dystrophic myoblasts with 
UTP causes a functional cellular response. As shown in Fig. 8, unstimulated mdx myoblasts 
are substantially more mobile than w/t cells and their motility was reduced in the presence of 
UTP. Although also observed in w/t cells, this effect has not been significant (Fig. 8). Some 
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degree of inhibition of this UTP action by AR-C118925XX additionally confirmed the role of 
P2RY2 receptor. Similar effect of UTP was previously described in leukaemic cells [40]. 
2.2 Calcium signalling toolkit 
In view of a high complexity of a regulation of intracellular calcium signalling, the 
increased [Ca
2+
]c upon stimulation of mdx myoblasts with ATP or UTP probably cannot be
explained exclusively by the elevated P2RY2 level in the plasma membrane. Therefore, to 
gain insight into this mechanism, we have analysed the RNA seq data for possible changes in 
expression of genes involved in calcium homoeostasis. Gene ontology analysis of genes 
showing differential expression in the dystrophic cells showed significant enrichment for 
genes involved in regulation of calcium ion transport into cytosol (p = 1.54e
-3
), whilst global
analysis of 870 genes involved in calcium ion transport, binding, and homeostasis functions 
identified significant modulation (both up and down-regulation) in dystrophic cells (Fig. 9).
To investigate this newly identified abnormality in calcium signalling, we have 
estimated a relative amount of Ca
2+
 stored in dystrophic and control myoblasts. Moreover,
levels of calcium signal transducing proteins linking P2RY2 receptor with the ER calcium 
stores have been compared. Fig. 10 A shows that a treatment of cells with ionomycin under 
Ca
2+
-free conditions resulted in a fast and transient increase of cytosolic Ca
2+
 concentration
due to Ca
2+
 release from intercellular stores. Since mitochondrial uncoupling with FCCP does
not influence Ca
2+
 concentration in cytosol (data not shown) it may be assumed that the entire
cytosolic Ca
2+
 originates from the ER. Ionomycin distributes evenly among cellular
membranes thus an elevation of cytosolic Ca
2+
 concentration is due to a fact that the Ca
2+
concentration between ER and cytosol equilibrates much faster than that between cytosol and 
extracellular milieu. It probably mirrors the proportion between surface area of the ER and 
PM membranes [41]. Though such a ploy does not allow calculating Ca
2+
 content in the ER in
the absolute units, it may be useful to compare a total amount of Ca
2+
 stored in various cells
or under different conditions. Thus, a greater increase of cytosolic Ca
2+
 concentration in mdx
myoblasts than in the w/t cells upon treatment with ionomycin indicates that the former 
accumulate more Ca
2+
 in the ER. Additionally, mdx myoblast contain more calsequestrin (Fig.
10 B) while the calreticulin level is unaltered by the mdx mutation (Fig. 10 C). This finding 
may suggest higher calcium storage capacity of mdx myoblasts and is in line with greater 
amount of Ca
2+
 released upon treatment of these cells with ionomycin (Fig. 10 A). In
addition, substantially elevated level of SERCA1 and SERCA2B proteins (Fig. 11), which are 
to reload ER stores with Ca
2+
, fits well with the concept of increased abundancy of cellular
calcium stores in mdx myoblasts. 
Altogether, these results may suggest that the increased calcium release in dystrophic 
cells results not only from the higher level of P2RY2 protein in the plasma membrane but also 
from the increased amount of Ca
2+
 stored. This could give a misguided impression of an
elevated P2RY2 activity or at least result in overestimation of its contribution to the intensity 
of calcium responses. Stimulation of P2RY2 activates signal transduction cascade, which may 
contribute to a regulation of the intensity of calcium response to metabotropic receptors 
stimuli. All results shown hitherto are clearly in line with an elevation of calcium release from 
the ER upon treatment of cells with ATP or UTP. Therefore, decreased level of Gq11 protein  
shown in Fig. 12 A have been unexpected. This protein mediates P2RY-dependent activation 
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of Ca
2+
 release from the ER, thus the decreased amount of it is inconsistent with a logical
assumption suggesting an enhanced signal transduction from P2RY2 to the ER. In contrast, Gi 
and Gs protein levels were unchanged in mdx myoblasts (data not shown).
In a view of the slightly elevated calcium content in the ER, it is tempting to speculate 
that lowered Gq/11 subunit  protein content may be an element of a cellular defence 
mechanism that protects myoblasts from an excessive Ca
2+
 release and increased cytosolic
Ca
2+
 concentration upon activation of P2YR2. This suggestion also concerns the substantially
reduced level of IP3 receptor (Fig. 12 B), which is responsible for Ca
2+
 release upon binding
IP3 produced from phosphatidylphosphoinositol, which hydrolysis is catalysed by PLC).          
On the other hand, a considerably increased level of PLC isoform 4 (Fig. 13 D), which is 
responsible for increasing IP3 concentration, is in line with increased Ca
2+
 release and could
counterbalance reduced protein G and IP3R content. To summarize, the significantly stronger 
calcium response of mdx myoblasts treated with ATP or UTP is probably a result of a few 
counteracting changes in specific proteins identified in this study.  
It must be stressed however, that Fura-2 allows measuring of cytosolic Ca
2+
concentration, which depends on two classes of events: Ca
2+
 entry into cytosol (from the ER
and extracellular space) and opposite processes responsible from Ca
2+
 removal from cells and
its uptake and storage by the ER. As shown in Fig. 14 cellular level of PMCA protein is 
substantially lower in mdx myoblasts than in the w/t cells. This Ca
2+
-pump exhibits high
affinity to calcium cation but it works relatively slowly, thus is thought to be responsible for 
maintaining low Ca
2+
 concentration in resting cells. On the other hand, an elevated level of
sodium-calcium exchangers (NCX1 and 3) suggests an increased efficiency of calcium 
removal during a recovery phase following cell excitation. This mechanism allows cells to 
restore resting Ca
2+
 concentration and presumably shapes [Ca
2+
]c transients. Data shown in
Fig. 14 suggest that Ca
2+
 transients due to calcium release from the ER, which are much
higher in the mdx myoblasts than in their control equivalents, may be attenuated by 
counteracting processes of Ca
2+
 removal from the cytosol.
Furthermore, to establish the compatibility with the data we previously obtained in 
mdx and w/t cells grown under “immorto”  conditions we have repeated selected experiments 
and confirmed the results in such cells (Fig Suppl. 1-6).  
4. Discussion:
Precise regulation of nucleotide-induced calcium signals is of high importance in 
stimulated and differentiating satellite cells. This may be accomplished due to a concerted 
activities of numerous “molecular tools” engaged in Ca2+ transport, sensing and storage,
which are involved in a spatio-temporal controlling of changes in local and global cytosolic 
[Ca
2+
]. Moreover, an excitation of cells via metabotropic receptors needs a contribution of
several factors, which form a signal-transforming cascades. Purinergic P2Y receptors belong 
to this category. Available data indicate that the pattern of their expression changes during 
muscle maturation from satellite cells through myoblasts to fully differentiated muscle fibres 
[42]. As a proliferation and differentiation of dystrophic myoblast seems to be accelerated in 
comparison to the w/t cells [13] it is probable that their nucleotide-evoked calcium response 
may differ [43, 44]. Previously we showed an increased susceptibility of mdx myoblasts to 
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P2XR7-mediated stimulation by ATP. It resulted in an accelerated calcium entry into mdx 
cells and was correlated with an elevated expression of P2XR7 protein [16]. Moreover, 
prolonged stimulation of mdx myoblasts with ATP or more selectively with P2RX7-specific 
agonist BzATP led to the opening of a large pore and additional effects such as stimulated 
autophagy and MMP-2 release [18, 45]. In these cells as well as in the primary mdx myoblasts 
an increased level of STIM1 protein seems to be behind significantly increased store-operated 
calcium entry (SOCE) [22 ]. In this paper the first step of cellular response to a stimulation of 
metabotropic nucleotide receptors, leading to a depletion of ER stores which is prerequisite 
for SOCE activation has been investigated. This is also the “metabotropic” complement to the 
previously characterized ionotropic response of mdx myoblasts to ATP [15]. 
All findings here together with those published previously [15, 22] clearly indicate 
that calcium signalling in mdx myoblasts and w/t cells varies and the amplitude of calcium 
response is always higher in the mdx myoblasts than in their w/t equivalents.  In this study 
mice myoblasts were stimulated with ATP or UTP under calcium-free conditions to avoid any 
P2X-dependent calcium entry (in a case of ATP as a stimulus) and an activation of the store-
operated calcium entry. Both agonists may activate P2RY2 and P2RY4. In fact, ATP may 
slightly activate some other P2RYs, however considering a particularly high selectivity of this 
nucleotide to P2RY2 and P2RY4, we focussed on P2RY2 and P2RY4 in further studies. 
Slightly lower response of cells to 1 mM than to 0.5 mM ATP may be due to additional 
effects coming from a stimulation of other ATP-sensitive proteins putatively leading to an 
reciprocal inactivation of proteins on the outer surface of the plasma membrane [45]. 
Discriminating between P2RY2 and P2RY4 activities is difficult because of the lack of 
satisfactorily specific spectrum of pharmacological tools including agonists and antagonists 
selective for each of the two types of P2RYs tested. However, lack of detectable P2RY4 
transcript expression in RNASeq and qPCR, a sensitivity to P2RY2-specific antagonist and 
inhibitory effect of silencing of P2RY2 expression indicate that P2RY2 is a predominant 
receptor activated in mdx myoblast treated with ATP under Ca
2+
-free conditions. Under these
circumstances, finding of an anti-P2RY4 reactive band in the total homogenate of mdx 
myoblasts was confusing. However, absence of P2RY4 protein in the plasma membrane of all 
tested cells excludes its contribution to the observed purinergic calcium response. P2RY4 
localised inside cells, presumably in an inactive form (e.g in secretory granules) but not in the 
plasma membrane might correspond to a freshly synthesised protein and point to “a higher 
readiness” of mdx cells to a response via a P2YR4-dependent mechanism to potential stimuli. 
Similar cytosolic localisation of P2RY4 was previously found in HT-29 human colon cancer 
cells [46]. Suppl. Figs. 4 and 5 also indicate lack of P2RY4 protein in the plasma membrane 
of immortalised w/t and mdx myoblasts. 
The nuclear staining with P2RY2 antibody probably reflects its poor specificity. In 
fact Western blot of proteins from isolated  nuclei  probed with P2RY2 antibodies showed a 
band corresponding to much smaller protein (data not shown) which intensity was insensitive 
to P2RY2 gene silencing.  
A functional identification of the P2RY2 as a receptor responsible for ATP/UTP-
induced metabotropic calcium response of mdx myoblasts together with elevated plasma 
membrane protein levels suggest a simple cause-effect explanation of increased susceptibility 
of dystrophic cells to this nucleotide. However, we uncovered a further significant modulation 
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of cellular calcium homeostasis in dystrophic myoblasts. 
RNASeq and biochemical data shown here indicate a set of changes which may affect 
calcium signalling in mdx myoblasts. They include changes in signal-transducing processes 
down-stream to the plasma membrane receptors. Subtle interplay between “on and off“ 
mechanisms leads to a balanced elevation of calcium responses, which fulfil the cellular 
demand. Final intensity of the calcium signal is a resultant of many, sometimes opposite, 
regulatory processes. Such a complex regulation prevents cell overloading with calcium. 
Increased amount of P2RY2 and PLC proteins as well as the increased abundance of the ER 
calcium stores may explain the increased Ca
2+
 release from the ER. On the other hand,
substantially reduced level of Gq11 subunit  and IP3R counteract the elevated signal 
transduction. It seems possible that the type of receptor decides the specificity of cellular 
response while its intensity might be further regulated by a very broad toolkit composed of 
proteins involved in calcium signalling. Special attention should also be paid to proteins 
involved in the restoration of the resting cytosolic Ca
2+
 concentration: NCX, SERCA and
PMCA as they are directly involved in regulating/shaping calcium signals regardless of a 
mechanism behind the induction of cellular calcium response.   
Thus, results shown here complement the general picture describing differences in the 
pattern of molecular tools (channels, pumps, exchangers, buffers) responsible for Ca
2+
homeostasis in w/t and mdx myoblasts. A scheme shown in Fig. 15 summarizes data shown 
here and in two previous papers [15, 22]. We propose that mdx mutation affects proportions 
between particular processes engaged in the intracellular calcium signalling.  
Results presented in this paper are in line with the hypothesis that phenotypic effects 
of mdx mutation occur as early as in undifferentiated muscle cells. Expression of full-length 
dystrophin transcripts in muscles is developmentally regulated: The satellite cells and 
proliferating myoblasts do not have detectable levels of dystrophin protein, while it is found 
in myotubes/myofibres. This observation, understandably, led to the commonly postulated 
hypothesis that dystrophin mutations would have an impact in differentiated muscles only 
and, as a result, research into the mutant phenotype has focused on the absence of dystrophin 
in myofibres sarcolemma. Thus phenotypic effects of the DMD mutations have usually been 
analysed in differentiated muscle cells as being unexpected at earlier stages of muscle 
development. In contrast to this well-established belief, many well documented experimental 
data indicate multiple phenotypic changes in undifferentiated cells with mutant dystrophin 
gene. Although the molecular mechanism behind such a broad spectrum of changes of [Ca
2+
]c
regulatory mechanisms caused by mdx mutation in mice myoblasts is still elusive, data shown 
here strengthen a hypothesis of a very early (in terms of muscle cell differentiation) onset of 
Duchenne type muscular dystrophy. It sheds new light on DMD pathophysiology and might 
be potentially important for pharmacological alleviation of DMD symptoms [5].  
We also demonstrated that these changes are due to Dmd gene mutation and not 
caused by cell immortalisation or being evoked by the effects of the dystrophic niche on 
primary myoblasts because these abnormalities are present in immortalized and de-
immortalized cells alike. However, the results shown here should be verified in primary mdx 
cells similarly to what was done in previous studies [22], which make the observations shown 
here more reliable.  
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5. Conclusion
Mdx myoblasts exhibit an elevated P2RY2 stimulation. Receptor overexpression determines 
the selectivity of cell response while the intensity of calcium signal seems dependent on the 
modulation of a set of proteins responsible for intracellular signal transduction, Ca
2+
 transport
and storage. Thus, the resultant Ca
2+
 response reflects activity of processes increasing [Ca
2+
]c
counterbalanced by mechanism, which prevent calcium overload.  Diverse responses of w/t 
and mdx myoblasts to ATP or UTP and significant differences in RNASeq profiles confirm 
the hypothesis that phenotypic effects of DMD mutation occur as early as in undifferentiated 
muscle cells.  
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Figure legends 
Fig 1.  RNAseq analysis in myoblasts derived from w/t  and mdx mice 
A: Hierarchical clustering of the normalised read counts across all genes identifies clear 
discrimination between the dystrophic (mdx) and control (w/t) cells. Cell colour represents 
the dissimilarity between samples, with dark blue indicating no difference. 
B: Volcano plot showing the results of the differential expression analyses across all genes, 
with the (-log10) adjusted p value on the y-axis representing the significance of the change, 
and the log2 fold change on the x-axis representing the magnitude of the change. Genes are 
classed as showing significant differential expression with fold change greater than 2-fold (up 
or down) with an adjusted p-value less than 0.05. In addition, the expression must show 
FPKM greater than 1 in at least one of the two conditions. Significantly upregulated (red) 
and downregulated (blue) genes between the mdx (SC5) and control (IMO) cells are 
highlighted 
Fig. 2 Heatmap of genes encoding members of the purinoceptor ATP receptor family 
 Variance stabilisation transformed read counts were normalised such that each row had 
mean 0 and standard deviation 1, such that differences between the mdx  and w/t cells could 
be identified, with downregulated genes highlighted blue and upregulated genes highlighted 
red. 
Fig. 3  Effect of ATP, UTP and AR-C118925XX on Ca
2+
 release from the ER stores in
myoblasts measured in the absence of extracellular calcium     
A, effect of ATP. Traces from one representative experiment out of three.        
B, Mean values collected from three experiments ± S.D.  Asterisks refer to statistically 
significant differences, as follows:   
mdx vs w/t (500 M ATP) *p<0.029;   
mdx vs w/t  (1 mM ATP) * p<0.027;
mdx vs mdx + 10 M AR-C118925XX (500 M ATP) * p<0.044;
mdx vs mdx +10 M AR-C118925XX (1 mM ATP) * p<0.030;
C, effect of UTP. Traces from one representative experiment out of five.     
D, Mean values collected from five experiments ± S.D.   Asterisks refer to statistically 
significant differences, as follows:       
mdx vs w/t (100 M UTP) * p< 0.001;
mdx vs w/t (500 M UTP) * p< 0.001;
mdx vs mdx + 10 M AR-C118925XX (100 M UTP) * p< 0.0003
mdx vs mdx + 10 M AR-C118925XX (500 M UTP) *p< 0.001;  
In this experiment fluorescence was measured with the use of Shimadzu 
spectrofluorospectrometer RF-5301 PC.  Dark bars – w/t myoblasts, bright bars – mdx 
myoblasts.  
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Fig. 4 P2RY2 and P2RY4 expression in w/t and mdx myoblasts. 
A, Mean values ± S.D. for  qPCR for P2RY2 and P2RY4 transcripts. Data collected from six 
and four experiments, respectively. * p<0.001 . B. Representative Western blots for P2RY2 
and P2RY4 and mean values ± S.D. of the relative level of these proteins in mdx myoblasts 
collected from three and six experiments, respectively. * p<0.02, ** p<0.05. 
Fig. 5 P2RY2 and P2RY4 localization to the plasma membrane 
A, Representative Western blot of P2RY2 and P2RY4 in cell fractions grown under “de-
immorto” conditions (as in the entire paper) normalised to Na+-K+ATPase. B, Representative
Western blot of P2RY2 and P2RY4 in crude homogenate and in the plasma membrane of w/t 
and mdx myoblasts  grown under “immorto” conditions, normalised to caveolin.  D, Mean 
values ± S.D. of Western blot data for P2RY2 normalised to caveolin “in immorto cells” for 
five independent experiments. E, Mean values ± S.D. of Western blot data for P2RY4 
normalised to caveolin in immorto cells for five independent experiments. * p<0.01,
** p<0.02.  
Fig. 6 Immunocytochemical detection of P2RY2 and P2RY4 in w/t and mdx myoblasts       
Upper panel: P2RY2. Increased amount of P2RY2 protein in a whole cell but particularly in 
the plasma membrane.  Lower panel: P2RY4. Increased total amount of P2RY4 with 
perinuclear localization in particular. Bar = 10 M  
 Fig. 7 Effect of P2Y2 gene silencing on UTP-evoked Ca2+ release from the ER stores in 
myoblasts measured in the absence of extracellular calcium   
Illustrative Western blot confirming an efficient silencing of the P2RY2 gene and nucleotide–
induced Ca
2+
 trace obtained in the same experiment. In this experiment fluorescence was
measured with the use of Hitachi fluorescence spectrophotometer F 7000. 
Fig. 8 Effect of UTP and AR-C118925XX on cell motility  
Myoblasts motility (cell path length) expressed in micrometers. Data collected from 3-5 
independent experiment.  
mdx unstimulated vs w/t  unstimulated p<0.014 n=5;   
mdx stimulated with UTP vs mdx unstimulated p<0.03 n=5.    
Fig. 9: Heatmap showing expression levels for genes associated with calcium ion 
homeostasis      
It is based on gene ontology terms calcium ion homeostasis (GO:0055074), calcium-mediated 
signaling (GO:0019722), calcium ion binding (GO:0005509), calcium ion transport 
(GO:0006816), or calcium channel activity (GO:0005262). Variance stabilisation 
transformed read counts were normalised such that each row had mean 0 and standard 
deviation 1, such that differences between the mdx and control (w/t) cells could be identified, 
with downregulated genes highlighted blue and upregulated genes highlighted red.   
Fig. 10 Relative calcium content in the ER and calsequestrin and calreticulin levels in w/t 
and mdx myoblasts.  
A, Increase of cytosolic Ca
2+
 concentration upon treatment of cells with ionomycin. Mean
value  of data collected from seven independent experiments ± SD. * p< 0.015.
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B, calsequestrin and C, calreticulin content in myoblasts. Representative Western blots and 
mean values ± S.D. collected from seven  experiments. *p<0.020  
Fig. 11 Relative amounts of SERCA1 and SERCA 2 in w/t and mdx myoblasts. 
Representative Western blot for SERCA1 and mean values ± S.D. of the relative level of these 
proteins in mdx myoblasts collected from four experiments. *p<0.022.Representative Western 
blot for SERCA2A and mean values ± S.D. of the relative level of these proteins in mdx 
myoblasts collected from four experiments. *p<0.006. Representative Western blot for 
SERCA2B and mean values ± S.D. of the relative level of these proteins in mdx myoblasts 
collected from four experiments.  n.s. 
Fig. 12 Relative amount of protein G11q subunit  and IP3R in wt and mdx myoblasts A, 
representative Western blot for Gq11 subunit  from one of three independent experiments, 
and mean values of data collected from three experiments. * p<0.047;  
B, representative Western blot for IP3R  from one of three independent experiments, and 
mean values of data collected from eight experiments. * p<0.016; 
Fig. 13  Relative amount of protein PLC isoforms 1-4  in w/t and mdx myoblasts.          
Each panel shows one representative Western blot out of four independent experiments and a 
mean values ± S.D of collected Western blot data. A, PLC1 n=4  p   0.29; B, PLC2 n=4 p 
≤ 0.552; C, PLC3 n=4 p ≤ 0.006; PLC4 n=3 p ≤ 0.004.  
Fig. 14 Relative amount of PMCA protein and NCX isoforms 1 and 3  in w/t and mdx 
myoblasts.  
Each panel shows one representative Western blot out of an indicated below number of 
independent experiments and a mean values ± S.D of collected Western blot data. A, PMCA 
n=6  p ≤ 0.04; B, NCX1 n=3 p ≤ 0.046; C, NCX3 n=4 p ≤ 0.016. 
Fig. 15 General scheme showing summarised results of our investigations concerning 
aberrant calcium homeostasis in mdx myoblasts.   
Left site presents data shown in this paper while on the right there are results of our previous 
study. Red characters or arrows mean increased protein levels or stimulated processes, 
respectively. Green -  decreased proteins levels. Black – unchanged or not determined.   
Suppl. Fig. 1. Effect of ATP, UTP on cytosolic calcium concentration in w/t and mdx 
myoblasts measured in the presence of extracellular calcium.   
A, Effect of  500 M ATP; B,  effect of 100 M UTP. [Ca2+]c was measured with Fura2-AM
in the presence of 2 mM CaCl2 in the extracellular solution. Figures shows representative 
traces out of 7 experiments for cells grown under “de-immortalizing” conditions as those 
applied in other experiments shown in this paper. Similar effects have been obtained in 
myoblasts grown under immortalizing conditions. In this experiment fluorescence was 
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measured with the use of Hitachi fluorescence spectrophotometer F 7000. Substantially 
higher elevation of [Ca2+]c in cells excited with ATP than with UTP reflects simultaneous 
ATP-evoked stimulation of metabotropic and ionotropic receptors (P2RY and P2RX, 
respectively). In this experiment fluorescence was measured with the use of Hitachi 
fluorescence spectrophotometer F 7000. 
Suppl. Fig. 2  Effect of ATP and AR-C118925XX on Ca
2+
 release from the ER stores in
myoblasts measured in the absence of extracellular calcium     
Upper panel: effect of ATP at various concentrations. Mean values collected from five 
experiments ± S.D.  
mdx vs w/t with 100 M ATP * p<0.026, 
mdx vs w/t with 500 M ATP * p<0.0001 
mdx vs w/t with 1 mM ATP * p<0.0001;
Lower panel: effect of ATP and P2RY2 antagonist (AR-C118925XX) . Asterisks refer to 
statistically significant differences, as follows:       
w/t vs. w/t + 10 M AR-C118925XX 500 M ATP *p<0.0003;
w/t vs. w/t +10 M AR-C118925XX  1 mM ATP * p<0.0005;  
mdx vs mdx + 3 M AR-C118925XX 500 M ATP * p<< 0.0001;
mdx vs mdx + 10 M AR-C118925XX 500 M ATP * p<< 0.0001         
mdx vs mdx + 3 M AR-C118925XX 1 mM ATP * p<< 0.0001;
mdx vs mdx + 10 M AR-C118925XX  1 mM ATP * p<< 0.0001 
Fluorescence (Fura-2) was measured with the use of Shimadzu spectrofluorospectrometer 
RF-5301 PC. Dark dots – w/t myoblasts, bright dots – mdx myoblasts.  
Suppl.   Fig. 3  Effect of UTP and AR-C118925XX on Ca2+ release from the ER stores in
myoblasts measured in the absence of extracellular calcium     
Upper panel: effect of UTP at various concentrations. Mean values collected from five 
experiments ± S.D. Asterisks refer to statistically significant differences, as follows: 
mdx vs w/t with 100 M UTP * p<<0.0001;  
mdx vs w/t with 500 M UTP * p<<0.0001          
mdx vs w/t with 1 mM UTP * p<<0.0001;  
Lower panel: effect of UTP and P2RY2 antagonist (AR-C118925XX) .        
w/t vs. w/t + 10 M AR-C118925XX  100 M UTP * p<0.002;
w/t vs. w/t + 10 M AR-C118925XX  500 M UTP * p<0.023;
mdx vs mdx + 3 M AR-C118925XX  100 M ATP * p<< 0.0001; 
mdx vs mdx + 10 M AR-C118925XX  100 M ATP * p<< 0.0001  
 Fura-2 fluorescence  was measured with the use of Shimadzu spectrofluorospectrometer RF-
5301 Dark dots – w/t myoblasts, bright dots – mdx myoblasts.  
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Suppl. Fig 4.  Representative Western blot of P2RY2 and P2RY4 in the plasma membrane 
of  cells  grown under “immorto” conditions  
A Representative Western blot of P2RY2 and P2RY4 in crude homogenate and in the 
plasma membrane of w/t and mdx myoblasts  grown under normalised to caveolin.  B, Mean 
values ± S.D. of Western blot data for P2RY2 normalised to caveolin for five independent 
experiments. E, Mean values ± S.D. of Western blot data for P2RY4 normalised to caveolin 
for five independent experiments. * p<0.01, ** p<0.02. 
Suppl. Fig. 5.  Immunocytochemical detection of P2RY2 and P2RY4 in w/t and mdx 
myoblasts   grown under “immorto” conditions  
Upper panel: P2RY2. Increased amount of P2RY2 protein in a whole cell but particularly in 
the plasma membrane.  Lower panel: P2RY4. Increased total amount of P2RY4 with 
perinuclear localization in particular. Bar = 10 M 
Suppl. 6  Effect of P2Y2 gene silencing on UTP-evoked Ca
2+
 release from the ER stores in
myoblasts measured in the absence of extracellular calcium   
Cells were grown under “immorto” conditions. Representative UTP–induced Ca2+ trace. In
this experiment fluorescence was measured with the use of Hitachi fluorescence 
spectrophotometer F 7000. 















